The Company has a portfolio of over 1,800 granted patents and almost 4,000 pending applications published for intellectual property generated during the development of its smoke-free products. PMI’s ambition is to develop, assess and commercialize products that have the potential to present less risk of harm compared with continued smoking and that ultimately benefit smokers, public health and society at large.